Table 3.
Clinical and imaging manifestations of craniopharyngiomas with and without third ventricular floor invasion.
| Project | The third ventricular floor invasion group (n=22) M (P25~ P75), n (%) |
The non-third ventricular floor invasion group (n=46) M (P25~ P75), n (%) |
Z | P |
|---|---|---|---|---|
| ACP | 14 (63.6) | 30 (65.22) | -0.127 | 0.899 |
| age | 44.5 (10~64) | 25 (4~82) | -2.249 | 0.025* |
| Male | 11 (50.0) | 25 (54.35) | -0.334 | 0.739 |
| Volume (cm3) | 18.50 (4.08~16.17) | 9.17 (5.54~16.80) | -0.151 | 0.507 |
| Texture | -0.664 | 0.507 | ||
| cystic | 8 (36.4) | 15 (32.61) | ||
| solid | 3 (13.6) | 3 (6.52) | ||
| cystic-solid | 11 (50) | 28 (60.87) | ||
| Necrosis | 12 (54.5) | 24 (52.17) | -0.182 | 0.856 |
| Liquid level or sediment | 1 (4.5) | 8 (17.39) | -1.452 | 0.147 |
| Calcification | 8 (36.4) | 17 (36.96) | -0.047 | 0.962 |
| Supratentorial hydrocephalus | 11 (50.0) | 15 (32.61) | -1.118 | 0.264 |
| Pituitary involvement | 18 (81.8) | 33 (71.74) | -0.891 | 0.373 |
| Pituitary stalk involvement | 4 (18.2) | 36 (78.26) | -0.337 | 0.736 |
| Hypothalamus involvement before Puget surgery | 21 (95.5) | 40 (86.96) | -1.071 | 0.284 |
*In the table indicates a statistically significant comparison.